Ahn-Gook Pharmaceutical Co. Ltd (001540.KQ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · South Korea · ISIN KR7001540004

Price
9,250.00 KRW
Market cap
105.13 bn KRW
P/E (2025)
14.05
P/S (2025)
0.34
Dividend yield
6.84 %
Net margin
2.44 %
Return on equity (ROE)
4.52 %
Return on assets (ROA)
2.41 %

Ahn-Gook Pharmaceutical Co. Ltd financials

Fiscal year20242025
Revenue271.12 bn KRW306.87 bn KRW
Gross profit167.90 bn KRW200.30 bn KRW
Operating income6.48 bn KRW9.82 bn KRW
EBIT23.24 bn KRW10.47 bn KRW
Net income16.85 bn KRW7.48 bn KRW
Diluted EPS – continuing operations1,482.17 KRW658.20 KRW

Full history since 2002, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Ahn-Gook Pharmaceutical Co. Ltd

Ahn-Gook Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products. The company's pharmaceutical products include Cinatura and Revo Tension. The company was founded in 1959 and is headquartered in Seoul, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.